McCormick & Company, Incorporated (MKC) Stock Forecast
Data as of Sep 16, 2026Consumer Defensive · Current price $50.13 (—)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 26, 2026 | Andrew Lazar | Barclays | $67.00 | +33.7% |
| Jan 23, 2026 | Bryan Adams | UBS | $67.00 | +33.7% |
| Jan 23, 2026 | Thomas Palmer | Coker Palmer | $72.00 | +43.6% |
| Dec 11, 2025 | Alexia Howard | Bernstein | $87.00 | +73.6% |
| Oct 8, 2025 | Alexia Howard | Bernstein | $93.00 | +85.5% |
| Oct 8, 2025 | Steve Powers | Deutsche Bank | $71.00 | +41.6% |
| Oct 8, 2025 | Andrew Lazar | Barclays | $72.00 | +43.6% |
| Oct 1, 2025 | Bryan Adams | UBS | $71.00 | +41.6% |
| Sep 25, 2025 | Thomas Palmer | Coker Palmer | $82.00 | +63.6% |
| Jun 17, 2025 | Thomas Palmer | Coker Palmer | $77.00 | +53.6% |
| Dec 9, 2024 | Rob Dickerson | Jefferies | $91.00 | +81.5% |
| Oct 22, 2024 | Rob Dickerson | Jefferies | $85.00 | +69.6% |
| Oct 2, 2024 | Matthew Smith | Stifel Nicolaus | $85.00 | +69.6% |
| Oct 1, 2024 | Adam Samuelson | Goldman Sachs | $69.00 | +37.7% |
| Oct 1, 2024 | Rob Dickerson | Jefferies | $86.00 | +71.6% |
| Oct 1, 2024 | Arun Sundaram | CFRA | $93.00 | +85.5% |
| Jun 28, 2024 | John Staszak | Argus Research | $80.00 | +59.6% |
| Jun 28, 2024 | Steve Powers | Deutsche Bank | $73.00 | +45.6% |
| Jun 12, 2024 | Thomas Palmer | Coker Palmer | $69.00 | +37.7% |
| Apr 2, 2024 | John Staszak | Argus Research | $88.00 | +75.6% |
Top Analysts Covering MKC
MKC vs Sector & Market
| Metric | MKC | Consumer Defensive Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.44 | 2.56 | 2.42 |
| Analyst Count | 16 | 10 | 18 |
| Target Upside | +14.0% | +1204.7% | +19.5% |
| P/E Ratio | 8.22 | 13.54 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-11-30 | $7.76B | $7.88B | $7.95B | 11 |
| 2027-02-28 | $1.97B | $1.99B | $2.01B | 3 |
| 2027-05-28 | $1.95B | $1.97B | $1.99B | 3 |
| 2027-08-28 | $2.03B | $2.05B | $2.07B | 3 |
| 2027-11-28 | $2.16B | $2.17B | $2.20B | 3 |
| 2027-11-30 | $8.13B | $8.17B | $8.21B | 9 |
| 2028-02-28 | $2.01B | $2.02B | $2.04B | 2 |
| 2028-05-28 | $2.02B | $2.04B | $2.06B | 2 |
| 2028-08-28 | $2.10B | $2.12B | $2.14B | 2 |
| 2028-11-28 | $2.23B | $2.24B | $2.27B | 2 |
| 2028-11-30 | $8.48B | $8.48B | $8.49B | 9 |
| 2029-11-30 | $8.82B | $8.92B | $9.01B | 4 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-11-30 | $3.08 | $3.10 | $3.13 | 8 |
| 2027-02-28 | $0.67 | $0.68 | $0.69 | 5 |
| 2027-05-28 | $0.75 | $0.75 | $0.76 | 4 |
| 2027-08-28 | $0.89 | $0.90 | $0.91 | 3 |
| 2027-11-28 | $0.96 | $0.96 | $0.98 | 2 |
| 2027-11-30 | $3.24 | $3.33 | $3.65 | 8 |
| 2028-02-28 | $0.76 | $0.77 | $0.78 | 3 |
| 2028-05-28 | $0.87 | $0.88 | $0.89 | 3 |
| 2028-08-28 | $0.95 | $0.96 | $0.98 | 3 |
| 2028-11-28 | $1.06 | $1.07 | $1.09 | 3 |
| 2028-11-30 | $3.46 | $3.65 | $3.83 | 6 |
| 2029-11-30 | $4.26 | $4.32 | $4.38 | 2 |
Frequently Asked Questions
What is the analyst consensus for MKC?
The consensus among 16 analysts covering McCormick & Company, Incorporated (MKC) is Buy with an average price target of $61.40.
What is the highest price target for MKC?
The highest price target for MKC is $93.00, set by Alexia Howard at Bernstein on 2025-10-08.
What is the lowest price target for MKC?
The lowest price target for MKC is $67.00, set by Bryan Adams at UBS on 2026-01-23.
How many analysts cover MKC?
16 analysts have issued ratings for McCormick & Company, Incorporated in the past 12 months.
Is MKC a buy or sell right now?
Based on 16 analyst ratings, MKC has a consensus rating of Buy (2.44/5) with a +14.0% upside to the consensus target of $61.40.
What are the earnings estimates for MKC?
Analysts estimate MKC will report EPS of $3.10 for the period ending 2026-11-30, with revenue estimated at $7.88B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.